NAFDAC Joins the World to Celebrate the 2025 Internation Women’s Day
Was this helpful? Yes No Submit Cancel Thanks for your feedback!
Blacklisting of Aveo Pharmaceuticals and Banning of Tapentadol and Carisoprodol Combination – Tafrodol or Royal 225
A company named Aveo Pharmaceuticals, based in the outskirts of Mumbai, managed by Vinod Sharma is involved in the production, sale and exportation of a range of addiction pills containing a harmful mix of Tapentadol (a powerful opioid), and Carisoprodol, a banned muscle relaxant with addictive properties that can cause overdose, or death. The mix […]
Public Alert No. 04/2025 – Public Alert on the Illegal Exportation and Sale of Opioids to West African Countries by Aveo Pharmaceuticals
The National Agency for Food and Drugs Administration and Control (NAFDAC) is informing the public of an investigational report from BBC revealing that an Indian pharmaceutical company Aveo Pharmaceuticals is manufacturing unlicensed, highly addictive opioids and exporting them illegally to some West African countries including Ghana, Nigeria, and Cote D’Ivoire, where they are constituting a […]
Public Alert No. 03/2025 – Alert on the Sale of Counterfeit/Falsified Petsow Starnicillin (Ampicillin) 500mg found in Cameroon and Central African Republic
The National Agency for Food and Drug Administration and Control (NAFDAC) is alerting the public about the sale and distribution of falsified PETSOW STARNICILLIN 500mg purportedly manufactured by Petsow Laboratories Limited. This falsified product was reportedly circulated in Cameroon and Central African Republic. The original and registered products are STARNICILLIN (500mg) with NAFDAC Reg. No. […]
Public Alert No. 02/2025 – Illegal Distribution and Sale of Substandard and Falsified (SF) Knowit Insulin Syringe 40 IU 29g X 1/2
The National Agency for Food and Drug Administration and Control (NAFDAC) is alerting the public about the illegal circulation and marketing of a substandard and falsified Knowit Insulin Syringe 40 IU 29g X 1/2 in Nigeria. The Association of Community Pharmacists of Nigeria (ACPN) raised concern regarding the ongoing use of 40 IU/ML insulin syringes […]
Public Alert No. 01/2025 – NAFDAC has Discontinued Registration of Multi-Dose Artemether /Lumefantrine Dry Powder for Oral Suspension
The National Agency for Food and Drug Administration and Control (NAFDAC) would like to inform the public that it has discontinued the registration of Multi-Dose Anti-Malarial (Artemether/Lumefantrine) dry powder for oral suspension. This decision was made due to the instability of the reconstituted formulations, which can lead to a loss of efficacy over time. This […]
The Year 2025 – NAFDAC Director General’s Strategic Plan
Reflection on the past seven years has brought into focus the many accomplishments that have been achieved in NAFDAC and so many others to be attained. This realization has sharpened my focus on how to strategically work towards continued strengthening of the regulatory system as a needed path toward safeguarding the health of the nation. […]
Public Alert No. 052/2024 – Alert of Confirmed Cases of Two Counterfeit Batches of Avastin 400mg/16ml, Manufactured By Roche Diagnostics Public Gmbh, Mannheim, Germany
The National Agency for Food and Drugs Administration and Control (NAFDAC) is notifying the public of two confirmed cases of two batches of counterfeit AVASTIN 400mg/16ml with batch number H0223B08 and H4239A70 in Nigeria. H0223B08 The Marketing Authorization Holder (MAH) Roche notified the Agency that a pharmacist reported the purchase of the counterfeited Avastin Vials […]
Public Alert No. 051/2024 -Alert on Confirmed Counterfeit PHESGO 600mg600mg/10ml With Batch Number C5290S20 Stated to be Manufactured by Roche S,P,A.
The National Agency for Food and Drugs Administration and Control (NAFDAC) wishes to inform healthcare providers and the public of a report of a suspected counterfeit Phesgo® 600mg/600mg/10ml, labeled with batch C5290S20. The Marketing Authorization Holder (MAH) Roche received a complaint from a doctor at Lagos University Teaching Hospital (LUTH-NSIA) reporting a suspected counterfeit Phesgo® 600mg/600mg, […]
Public Alert No. 050/2024 -Alert on the Recall of Apo-Amitriptyline 10mg and 25mg Manufactured by Pharma Forte Singapore Pte Ltd.
The National Agency for Food and Drugs Administration and Control (NAFDAC) is notifying the public that the Health Sciences Authority (HAS) of Singapore has announced the recall of eight (8) batches of Apo-Amitriptyline 10mg and three (3) batches of Apo-Amitriptyline 25mg tablets, manufactured by Pharma Forte Singapore Pte Ltd. The affected batches were recalled due […]
